Cancer drug scandal raises international concerns

The article addresses the scandal of cancer medications in Lebanon, highlighting the risks associated with the proliferation of substandard drugs imported from unreliable sources such as Iran, India, and China, along with some exceptional licenses that could lead to a health catastrophe. It also focuses on the judiciary's move to investigate issues of manipulation and embezzlement, including re-examination of samples in external laboratories to ensure their quality. The piece notes that the ministry is exceeding international standards by registering medicines from untrustworthy origins, raising questions about sample substitutions and the possibility of a mafia controlling the pharmaceutical market. It also proposes a law aimed at regulating licensing and registration processes to ensure the quality of medicines provided to citizens.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل